Literature DB >> 26927992

Populations of latent Mycobacterium tuberculosis lack a cell wall: Isolation, visualization, and whole-genome characterization.

Ali Akbar Velayati1, Thomas Abeel2, Terrance Shea3, Gennady Konstantinovich Zhavnerko4, Bruce Birren3, Gail H Cassell5, Ashlee M Earl3, Sven Hoffner6, Parissa Farnia7.   

Abstract

OBJECTIVE/
BACKGROUND: Mycobacterium tuberculosis (MTB) causes active tuberculosis (TB) in only a small percentage of infected people. In most cases, the infection is clinically latent, where bacilli can persist in human hosts for years without causing disease. Surprisingly, the biology of such persister cells is largely unknown. This study describes the isolation, identification, and whole-genome sequencing (WGS) of latent TB bacilli after 782days (26months) of latency (the ability of MTB bacilli to lie persistent).
METHODS: The in vitro double-stress model of latency (oxygen and nutrition) was designed for MTB culture. After 26months of latency, MTB cells that persisted were isolated and investigated under light and atomic force microscopy. Spoligotyping and WGS were performed to verify the identity of the strain.
RESULTS: We established a culture medium in which MTB bacilli arrest their growth, reduce their size (0.3-0.1μm), lose their acid fastness (85-90%) and change their shape. Spoligopatterns of latent cells were identical to original H37Rv, with differences observed at spacers two and 14. WGS revealed only a few genetic changes relative to the already published H37Rv reference genome. Among these was a large 2064-bp insertion (RvD6), which was originally detected in both H37Ra and CDC1551, but not H37Rv.
CONCLUSION: Here, we show cell-wall free cells of MTB bacilli in their latent state, and the biological adaptation of these cells was more phenotypic in nature than genomic. These cell-wall free cells represent a good model for understanding the nature of TB latency.
Copyright © 2015 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mycobacterium tuberculosis; Tuberculosis latency; Whole-genome sequencing

Mesh:

Year:  2015        PMID: 26927992      PMCID: PMC5443679          DOI: 10.1016/j.ijmyco.2015.12.001

Source DB:  PubMed          Journal:  Int J Mycobacteriol        ISSN: 2212-5531


  41 in total

1.  Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-12-09       Impact factor: 17.586

Review 2.  Much's granules revisited.

Authors:  J L Stanford
Journal:  Tubercle       Date:  1987-12

3.  Oxygen depletion-induced dormancy in Mycobacterium bovis BCG.

Authors:  A Lim; M Eleuterio; B Hutter; B Murugasu-Oei; T Dick
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

4.  Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection.

Authors:  R Hernández-Pando; M Jeyanathan; G Mengistu; D Aguilar; H Orozco; M Harboe; G A Rook; G Bjune
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

5.  Mycobacterium under AFM tip: Advantages of polyelectrolyte modified substrate.

Authors:  Genady Zhavnerko; Nikolai Nikolaevich Poleschuyk
Journal:  Int J Mycobacteriol       Date:  2012-02-02

6.  Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions.

Authors:  L G Wayne
Journal:  Am Rev Respir Dis       Date:  1976-10

7.  Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability.

Authors:  Martin Gengenbacher; Srinivasa P S Rao; Kevin Pethe; Thomas Dick
Journal:  Microbiology       Date:  2009-10-01       Impact factor: 2.777

8.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

9.  A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen.

Authors:  Chirajyoti Deb; Chang-Muk Lee; Vinod S Dubey; Jaiyanth Daniel; Bassam Abomoelak; Tatiana D Sirakova; Santosh Pawar; Linda Rogers; Pappachan E Kolattukudy
Journal:  PLoS One       Date:  2009-06-29       Impact factor: 3.240

10.  A predictive signature gene set for discriminating active from latent tuberculosis in Warao Amerindian children.

Authors:  Lilly M Verhagen; Aldert Zomer; Mailis Maes; Julian A Villalba; Berenice Del Nogal; Marc Eleveld; Sacha Aft van Hijum; Jacobus H de Waard; Peter Wm Hermans
Journal:  BMC Genomics       Date:  2013-02-01       Impact factor: 3.969

View more
  11 in total

Review 1.  Opening Pandora's Box: Mechanisms of Mycobacterium tuberculosis Resuscitation.

Authors:  Ashley V Veatch; Deepak Kaushal
Journal:  Trends Microbiol       Date:  2017-09-11       Impact factor: 17.079

Review 2.  Isoniazid and host immune system interactions: A proposal for a novel comprehensive mode of action.

Authors:  Saifur R Khan; Yousef Manialawy; Arno G Siraki
Journal:  Br J Pharmacol       Date:  2019-11-12       Impact factor: 8.739

Review 3.  Exosomes and Exosomal miRNA in Respiratory Diseases.

Authors:  Shamila D Alipoor; Esmaeil Mortaz; Johan Garssen; Masoud Movassaghi; Mehdi Mirsaeidi; Ian M Adcock
Journal:  Mediators Inflamm       Date:  2016-09-25       Impact factor: 4.711

4.  RNA Profiling Analysis of the Serum Exosomes Derived from Patients with Active and Latent Mycobacterium tuberculosis Infection.

Authors:  Lingna Lv; Cuidan Li; Xiuli Zhang; Nan Ding; Tianshu Cao; Xinmiao Jia; Jinghui Wang; Liping Pan; Hongyan Jia; Zihui Li; Ju Zhang; Fei Chen; Zongde Zhang
Journal:  Front Microbiol       Date:  2017-06-12       Impact factor: 5.640

5.  Mycobacterium tuberculosis DosR Regulon Gene Rv2004c Encodes a Novel Antigen with Pro-inflammatory Functions and Potential Diagnostic Application for Detection of Latent Tuberculosis.

Authors:  Sankara Narayana Doddam; Vidyullatha Peddireddy; Niyaz Ahmed
Journal:  Front Immunol       Date:  2017-06-24       Impact factor: 7.561

6.  SMRT genome assembly corrects reference errors, resolving the genetic basis of virulence in Mycobacterium tuberculosis.

Authors:  Afif Elghraoui; Samuel J Modlin; Faramarz Valafar
Journal:  BMC Genomics       Date:  2017-04-17       Impact factor: 3.969

7.  Immunogenicity and Safety of the M72/AS01E Candidate Vaccine Against Tuberculosis: A Meta-Analysis.

Authors:  Zhenhua Ji; Miaomiao Jian; Taigui Chen; Lisha Luo; Lianbao Li; Xiting Dai; Ruolan Bai; Zhe Ding; Yunfeng Bi; Shiyuan Wen; Guozhong Zhou; Manzama-Esso Abi; Aihua Liu; Fukai Bao
Journal:  Front Immunol       Date:  2019-09-03       Impact factor: 7.561

8.  The Systematic Review and Meta-Analysis on the Immunogenicity and Safety of the Tuberculosis Subunit Vaccines M72/AS01E and MVA85A.

Authors:  Inayat Ullah; Shaheen Bibi; Ijaz Ul Haq; Kifayat Ullah; Long Ge; Xintong Shi; Ma Bin; Hongxia Niu; Jinhui Tian; Bingdong Zhu
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561

Review 9.  The emerging role of exosomal miRNAs as a diagnostic and therapeutic biomarker in Mycobacterium tuberculosis infection.

Authors:  Rasoul Mirzaei; Sajad Babakhani; Parisa Ajorloo; Razieh Heidari Ahmadi; Seyed Reza Hosseini-Fard; Hossein Keyvani; Yaghoub Ahmadyousefi; Ali Teimoori; Farhad Zamani; Sajad Karampoor; Rasoul Yousefimashouf
Journal:  Mol Med       Date:  2021-04-01       Impact factor: 6.354

10.  Multifaceted remodeling by vitamin C boosts sensitivity of Mycobacterium tuberculosis subpopulations to combination treatment by anti-tubercular drugs.

Authors:  Kriti Sikri; Priyanka Duggal; Chanchal Kumar; Sakshi Dhingra Batra; Atul Vashist; Ashima Bhaskar; Kritika Tripathi; Tavpritesh Sethi; Amit Singh; Jaya Sivaswami Tyagi
Journal:  Redox Biol       Date:  2018-01-03       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.